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The absorption of a pyrethroid insecticide, cypennethrin, 
through rat skin has been measured both in vitro and in 
vivo. Cypermethrin did not penetrate in vitro through whole 
skin but did penetrate epidermal membranes . The in vitro 
absorption was influenced by the choice of receptor fluid 
in the glass diffusion cell. There was good agreement be-
tween in vivo and in vitro data using 50% aqueous ethanol , 
6% Volpo 20, or total calf serum receptor fluids. Rat epi-
M any pesticides during manufacture and use have the potential to contact skin and be absorbed. Consequently, part o f the necessary sa fety eval-uation involves an assess ment of percutaneous absorption rate. 
Often , assessments involve the application of the chemical to 
the intact skin of a living animal (typically a rat) and a determi-
nation of the extent of absorption made by examination of body 
Auids and tissues. Such methods require substantial technical skill, 
much time, and the use of live animals [1] . Confident extrapo-
lation of the derived data to humans is often questionable as the 
permeability of human skin has been shown to be less permea ble 
than animal 'skin to a wide range of chemicals and no ideal animal 
model has been reported [2-5]. The monkey has been shown to 
have similar permeability to human skin for a small range of well-
absorbed nitroaromatic compounds [6], but with more poorly 
absorbed molecules significant di fferences might be found. 
During the pas t 20 yea rs, the fac tors governing the percuta-
neous absorption of chemicals have been studied using in vitro 
methods [7- 9]. The rationale for this approach is that the rate of 
absorption is governed by diffusion through the dead, outer layer 
of the epidermis, the stratum corneum [8], and that there is no 
active transport [1 0]. There have been many publications describ-
ing the utilization of this technique with many different types of 
chemicals [11-13] ; however, there are fewer publications dem-
onstrating that in vitro results are in agreement with in vivo results 
[6, 14-16]. 
We have measured the in vivo percutaneous abso rption of the 
pesticide cyperm ethrin after applica tion to rat skin, formul ated 
in a typical formul ation. The formulation was applied in small , 
finite amounts as might contact a spray operator under field ap-
plica tion conditions (personal communication from Me. G. C hes-
ter, IC l pic, 1985). 
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dermal membranes in vitro were more than 20 times more 
permeable to cypermethrin than human epidermal mem-
branes, indica ting that cypermethrin would be less readily 
absorbed in humans than in the rat. 
The percutaneous absorption in vitro technique using 
epidermal membranes was successfuJl y used with this li-
pophilic chemical to predict the in vivo absorption in the 
rat . ] Invest DeY/natol 89:142-146, 1987 
The percentage of the applied dose absorbed after 8-h contact 
was measured and , separately, the profile of the absorption over 
24 h. Parallel in vitro studies measured cypermethrin absorption 
through excised rat and human cadaver skin (using both whole 
skin and epidermal membranes). To facilitate analysis and alloW 
a more accurate assess ment of absorption , [14C]cypermethrin was 
added to the formulation . 
In these studies, we have been primarily concerned with the 
definiti on of the amount of chemi cals that might be absorbed in 
a specific time period and produce general, ra ther than local ef-
fects. We have therefore considered a chemical to be absorbed 
when it has ac tually diffused throu gh the epidermis. 
MA TERIALS AND METHO DS 
Radiochemicals (±) a-Cyano-3-phenoxybenzyl ( ± ) cis tra l'lS-
3-(2,2,-dichlorovinyl)-2,2-dimethyl cyclopropanecarboxylate 
(trivial name cypermethrin) was supplied by IC I pic, Plant Pro-
tection Division, Fernhurst, Sussex, U . K. as [1 4C]cycloprop-la-
beled cis-cy permethrin (1. 9 GBq mmol- I ) and [14C)cycloprop-
labeled tral1s-cypermethrin (2.0 GBq mmol- I ). Both isomers were 
purified by high-performance liquid chromatography to a radio-
chemical purity of > 97% as determined by thin-layer chroma-
tography. The isomers were mixed to give a cis- cypermethrin 
to trans-cypermethrin ratio of 50. 2 : 49.8. T wo cypermethrin dos-
ing solutions were prepared; a concentrate formulation of 359 
g/liter and an oil based spray dilution of 29 g/liter. The dosing 
solutions were monitored for stability throughout the study and 
at all times the radiochemical purity was >97%. 
Tritiated water was supplied by Amersham International, 
Buckinghamshire, U .K. and w as diluted for use to 0.1 MBq 
ml - I . 
In Vitro Studies Human abdominal skin was obtained from 
autopsy and the subcutaneous fat removed . Human epidermal 
sheets were separated from full-thickness skin by immersing in 
water at 60°C for 45 s and gently peeling aw ay the epidermis 
[17]. Excised skin from the dorsolumbar region of 4- to 5-week-
old rats (Alpkl AP strain , Wistar derived) was used . Rat epidermal 
sheets were prepared by soaking in 2 M N aBr solution before 
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Figure 1 : Diffusion Cell- Horizontal Membrane 
Figure 1. Diagram of the glass diffusion cell used in the experiments. 
gently peeling away the epidermis [17). Membranes that were 
not used immediately were wrapped in aluminium foil and stored 
at 4°C for up to 2 weeks. 
Both whole skin and epidermal membranes were mounted in 
horizontal glass diffusion cells and exposed to ambient conditions 
(Fig 1) . The exposed area of tissue between the donor and receptor 
chambers was 2.54 cm2 
Prior to the application of the formulations the integrity of each 
membrane was assessed by determining the permeability to tri-
tiated water [11] over a 6-h period. Cells that had intact mem-
branes were then left overnight with a small volume of saline (0.5 
mJ) in the receptor chamber (capacity 4.5 ml) to maintain a high 
relative humidity, and the epidermal surface left exposed to the 
atmosphere. Test chemicals were then applied to the intact epi-
dermal membranes on the next day. 
In the first series of in vitro experiments, the percutaneous 
absorption of [1 4C]cypermethrin from the concentrate and spray 
dilution formulations through human and rat whole skin and 
epidermal membranes during an 8-h exposure was measured. 
The concentrate formulation (3 ILl application dispensed from a 
Hamilton microsyringe) or spray dilution (0.5 ILl application dis-
pensed from a 1-1L1 Hamilton microsyringe) was applied to in-
dividual membranes . The receptor fluids used were saline, 50% 
v/v aqueous ethanol, 6% w/v Volpo 20 in saline, 20% fetal calf 
serum in saline, and 6% polyethylene glycol (PEG-400) in saline. 
In the second series of in vitro experiments, designed to assess 
the time-related absorption of cypermethrin during a 32-h time 
period, from the spray dilution formulation through human and 
rat epidermal membranes, a dose of 5 ILl cm - 2 was applied to the 
skin. The receptor fluids used were 50% v/v aqueous ethanol and 
6% w/v Vol po 20 in saline. In both series of experiments frequent 
receptor samples were taken for radiochemica1 analysis on a BE-
TAmatic II (Kontron Instruments, Welwyn Garden City, Her-
efordshire, U.K.) and dpm values calculated using quench cor-
rection data . Results were expressed as percent dose absorbed. 
In Vivo Studies The absorption of [14C)cypermethrin from 
concentrate and spray dilution formulations through skin of the 
dorsolumbar region of 4- to 5-week-old rats was determined. Fur 
from the dorsolumbar region was removed using animal clippers 
24-30 h before dosing and only animals with clinically normal 
skin used. 
The concentrate formulation (3 ILl) was applied to the shorn 
backs of lightly anesthetized rats and a plastic guard (completely 
open to the atmosphere) was glued around the application site 
using cyanoacrylate ester glue (Loctite, Welwyn Garden City, 
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Herts , U.K.). Back scratching was prevented by wrapping rubber 
tubing around the body as previously described [18] . Each animal 
was placed in an individual metabolism cage designed for the 
separate collection of urine and feces . Eight hours after dosing, 
the rats were humanely sacrificed and blood samples taken by 
cardiac puncture into lithium heparin tubes. A range of tissues 
was taken for analysis: liver, both kidneys, and skin from the 
application site. Residual urine was taken from the bladder and 
added to the voided urine. The residual carcass was stored at 
- 40°C for later analysis . 
In a second series of in vivo experiments designed to determine 
the time course of dermal absorption of cypermethrin from the 
spray dilution formul ation , 20 ILl of spray dilution formul ation 
was applied evenly over a predefmed area of 4 cm2 using a Ham-
ilton microsyringe . Animals (3 rats per group) were sacrificed at 
4, 8, 12, and 24 h and samples taken as before. 
Sample Preparation Duplicate 0.2-ml aliquots of the urine 
samples were mixed with 10 ml ofOptiphase "MP" (Fisons pic, 
Loughborough, U .K.) in plas tic scintillation vials (Packard, Il-
linois) and the radioactivity determined by liquid scintillation 
counting. 
Skin samples were solubilized in Soluene-350 (Packard) and 
duplicate weighed samples were mixed with 10 ILl of Dimilume-
30 (Packard) in glass scintillation vials (Packard) and the radio-
activity determined by liquid scintillation counting. 
Fecal samples were suspended in methanol and homogenized 
using an Ultra-Turrax homogenizer (Sartorius IKA, Belmont, 
Surrey, U.K.) fitted with a lOS probe. The samples were cen-
trifuged at 1000 g for 10 min in an IEC Centra-7R [Damon/lEC 
(U .K.) Ltd, Dunstable, Bedfordshire, U.K.] and duplicate 0.2-
ml aliquots mixed with 10 ml ofOptiphase " MP" and taken for 
liquid scintillation counting. The fecal residue was dried and ground 
to a fine powder using a mortar and pestle. 
The individual carcasses were mixed with twice their weight 
of rat chow and minced to a fine homogenous powder using a 
Hobart E4522 mincer (Hobart Manufacturing Co Ltd, London, 
U .K.). 
Blood, liver, kidney, ground fecal residue, and carcass were 
prepared for radiochemical analysis usin g a Packard Tri ca rb 306 
sample oxidizer (Packard). The resulting CO2 was absorbed in 8 
ml of Optiphase I (Fisons pic) and admixed with 12 ml of Op-
tiphase "S" scintillant (Fisons pic). Aliquots of[l4C)cypermethrin 
containing 40,000 dpm were used to determine the overall com-
bustion efficiency. 
All sample liquid scintillation counting was done on aBET A-
matic II counter with the appropriate quench correction data loaded 
into the memory of the machine. 
RESULTS 
Following the in vivo dermal application of the concentrate for-
mulation to the rat, 1.0% (SEM ± 0.4%; n = 3; equivalent to 
10.9 ± 4.0 ILg cm - 2 cypermethrin) of the total recovered dose 
was absorbed during the 8-h exposure time. 
From the parallel in vitro studies no cypermethrin was absorbed 
(limit of determination <0. 1 % of the recovered dose) from either 
the concentrate or spray dilution, during the 8-h application ex-
posure of whole human or rat skin (Table I). When rat epidermal 
membranes were used, with 50% aqueous ethanol, 6% Vol po 
20, or 20% fetal calf serum as the receptor fluids, absorption of 
cypermethrin from both the concentrate and spray dilution for-
mulations was detected. However, absorption was detected only 
through human epidermal membranes with 50% aq ueous ethanol 
as the receptor fluid (Table I). 
Figure 2 shows the profile of cypermethrin absorption from 
the in vitro (using 50% aqueous ethanol and 6% Volpo 20 as the 
receptor fluids) and in vivo time course study. The in vivo ab-
sorption profile was very similar to the in vitro profiles. During 
the initial 12 h there was no significant difference between the in 
vivo and in vitro data; however, at 24 h the in vitro experiment 
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Figure 2. Pro fil e of the time course of [' 4C)cypermethrin absorption 
measured in vivo (Iriallg/es) and in vitro using 50% aqueous ethanol (sqllares) 
and 6% Volpo 20 in saline (circles) as the receptor flui ds. 
using the 6% Volpo 20 receptor fluid underes timated the in vivo 
abso rption . 
DI SCUSSION 
The results from the in vivo studies on the percutaneous abso rp-
tion of cypermethrin form the basis for comparison with the in 
vitro res ults. The doses selected for application to the skin were 
small and representative of the estimated amounts which could 
contact workers in normal practice. Many in vit ro studies have 
previously been criticized , as the amounts applied to the skin were 
excessive compared with the prac ti cal in vivo situation; this was 
not the case in this study. By precisely matching the applications 
in vivo and in vit ro any di ffe rences detected could not be ascribed 
to the app lica tion regime. 
We have considered the chemi cal as percutaneously abso rbed 
once it has reached the systemic circulation, which is located 
benea th the dermal-epidermal junction. C hemical that was still 
on, or in, the skin was not considered as absorbed at the termi-
nation of the study. In vi vo only 1.0% of the applied cyper-
methrin was absorbed in 8 h following application of the con-
centrate formul ation . Although precise comparisons cannot be 
made due to differences in doses and vehicles, this is low when 
compared to other pesticides that have been studied in vivo through 
human [19] and animal skins [1, 20, 21] . 
The epidermal membranes used in these experiments are di f-
ferent from skin slices which have been used by other workers 
[6] as they do not contain any dermis [17], a barrier to lipophilic 
molecules in vitro but not in vivo . The receptor fluid s were se-
lected both to have a range of solu bility properties and to reflect 
normal body fluid s (saline and fetal calf serum): similar recepror 
fluid s have previously been used [22]. 
Previous percutaneous absorption studies with lipophili c mol-
ecules have show n that in vitro the aqueous dermis can act as a 
signifi cant, additional, artificial barrier [8]: penetrating molecules 
enter the sys temic circulation in vivo at the top of the dermis and 
do not have to traverse its full thi ckness. Other in vitro studies 
[22] with lipophilic molecules have reported poor agreement com-
pared with in vivo human data [1 9] rather than the good agree-
ment achieved with more water-soluble molecules. The in vit ro 
results indica ted lower absorption for the lipophilic molecules 
than expected and the res ults were probably influenced by the 
presence of the dermis. As anticipated, the dermis influenced 
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abso rption of cypcrmethrin in vitro, durin g thc 8-h exposurc 
time, through both hum an and rat w hole skin (Table I). Whcn 
epidermal membranes were uscd, however, we were able to quan-
tify thc absorption of cypermethrin . 
The influence of the dermis as an extra barricr to the abso rption 
of lipop hilic molecu les has also been repo rted in in vivo studics 
w ith human sk in transplanted onto athymic mousc skin [23]. 
Good agreement was seen betwcen the permca bility of th e trans-
planted human skin and published human in vivo data [1 9] for 
water-soluble chcmi ca ls but poo rer agreement was seen w ith the 
more lipophili c molecu les. In the gra fted skin, the dcrmis was 
abnorm all y thick and poorly vascularized and might have acted 
as an additi onal barri er to the lipophilic molecules. 
T he necess ity of a suitable reccptor fluid in in vitro percutaneous 
abso rption assess mcnts has been reported [22] and we have con-
firmed that the various receptor fluids chosen for our stud y in-
flu enced the absorption of cypermethrin . The highest absorption 
was measured w ith 50% aqueous ethanol as the receptor fluid 
and, although absorption measurcd with the other two receptor 
fluids w ith lipid-soluble properties (6% Volpo 20 and 20% fetal 
calf seru m) was very similar, no absorption was detected w ith 
the other receptor fluid s. These results reinforce the view that the 
choice of a receptor fluid in w hi ch the penetratin g molecule is 
highl y soluble is necessa ry for successful in vitro measurements. 
Otherwise, solubility in th e receptor phase, rather than diffusion 
through the epidermis, will be the rate-limiting step . 
It is apparent with the concentrate formulation, that there was 
a similar magnitude of absorption measured in the in vivo ex-
periments and the in vitro experiments (when appropriate skin 
membrane and suitable receptor fluid were used). The results 
indicate sl ightl y g rea ter absorption in vitro than in vivo. The 
absorption measured in vivo was vcry low and even w ith the use 
of a radiolabeled molecul e there arc signifi cant analytic difficulties 
in obtaining determinations from tissues. 
Based on these data, the in vitro absorption of cypermethrin 
wi th time was measured from the spray dilution fo rmulation 
through rat epidermal membrane and 50% aqucous ethanol and 
6% Volpo 20 as the receptor fluids . Fetal ca lf serum was not 
suitable for use over long time periods . The results were com-
pared to data from an equivalent in vivo stud y (Fig 2). The ab-
sorption was greatcr with the 50% aqueous ethanol receptor fluid 
than with the 6% Volpo 20 in sa linc, although the abso rption 
profiles were similar. The in vivo profile showed a good co rre-
lat ion w ith th e in vitro profilcs, using both receptor fluid s up to 
12 h. At 24 h thcrc was still good agrccment between th e in vivo 
data and in vitro data using the 50% aqueous ethanol as the 
receptor fluid , but th e results with the 6% Vol po 20 recepto r fluid 
underestimated the in vivo absorption of cypermethrin . A similar 
in vitro underestimation of in vivo absorption, though with a 
similar absorption profile, has been seen with other lipophilic 
molecules w hen 6% Vol po 20 in sa line was used as the rcceptor 
fl uid [22]. 
These studies have confirmed thc marked species differences 
in percutaneous absorption that ca n occur. Any assessmcn t of the 
percutaneous absorption of cypermethrin, using rat skin , w ill lead 
to an overestimation of potential human absorption. We have 
show n [2] that not on ly th e rat, but other common laboratory 
animals, are poor models for human skin permeability , particu-
larl y with slowly absorbed chemica ls. H owever, the in vitro tech-
nique provides a method for quantifying the difference in the 
permeability properties of human and animal skin . T he only data 
that allow a quantitation of the difference in the permeability of 
human and rat skin to cypermethrin are those using the spra y 
di lution , epidermal membranes, and 50% aqueous ethanol re-
ceptor fluid. In these experiments, human skin was 24 times less 
permea ble to cypermethrin than rat skin . With the other receptor 
fluids used, ifit is assumed that 0. 1 % was actuall y absorbed, these 
experiments indicate that rat skin is 17-32 times more permeable 
than human sk in . 
This study has shown that an understanding of the technical 
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difficulti cs and limitations of th e in vitro percutaneous absorption 
technique allows experim ents to be don e which give data in good 
agreement with in vivo data. Once the influen ce of the type of 
membrane and recep tor fluid are understood , data can be obtained 
for a wide range of molecules w ith different ph ysicochemical 
properties . In vitro assess mcnts are less demanding than in vivo 
experiments, and furth er understandin g of the in vitro technique 
should promote its wider acceptance and mi ght reduce the need 
for many in vivo studies. 
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